COMMUNIQUÉS West-GlobeNewswire

Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
17/02/2026
Leiden, the Netherlands, February 17, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced its participation in the Oppenheimer 36 th Annual Healthcare Life [...]
Change to the Roche Enlarged Corporate Executive Committee
17/02/2026
Basel, 17 February 2026 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Mark Dawson, M.D., Ph.D., as the new Head of Roche Pharma Research and Early Development (pRED), effective 1 May 2026. [...]
FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference
17/02/2026
Presentation will highlight lead clinical candidate FMP374, a novel dual-acting NMDAR modulator advancing toward IND-enabling studies for TRD HEIDELBERG, Germany, Feb. 17, 2026 (GLOBE NEWSWIRE) -- FundaMental Pharma [...]
Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance
17/02/2026
15% royalty income increase 11% total revenue increase Tripled net cash position Phase 3 program with fosmanogepix progressing as planned Financial guidance FY 2026: Double-digit increase in total revenue and operating [...]
FIRST PATIENT DOSED IN CITRYLL’S IMAGING STUDY EVALUATING DISTRIBUTION AND TARGET ENGAGEMENT OF CIT-013
17/02/2026
PET-based imaging study designed to assess the biodistribution of CIT-013 and associate disease activity with CIT-013 target disposition in participants with rheumatoid arthritis and hidradenitis suppurativa Findings [...]
Inventiva reports preliminary 2025¹ fiscal year financial results
17/02/2026
Cash and cash equivalents at €99.3 million, and €131.6 million in short-term deposits 2 as of December 31, 2025 Revenues of €4.5 million in 2025 Completed a U.S. registered public offering for gross proceeds of [...]
Inventiva publie ses résultats financiers préliminaires pour l’exercice 2025¹
17/02/2026
Trésorerie et équivalents de trésorerie à 99,3 millions d’euros, et 131,6 millions d’euros en dépôts à court terme 2 au 31 décembre 2025 Chiffre d’affaires de 4,5 millions d’euros en 2025 Réalisation d’une offre au [...]
Galapagos Receives Transparency Notification from Bank of America
16/02/2026
Mechelen, Belgium ; February 16, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Bank of America. Pursuant to Belgian transparency [...]
Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
16/02/2026
Management will participate in three upcoming investor healthcare conferences SALT LAKE CITY, Feb. 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular testing and precision medicine [...]
Matterhorn Fit Debuts in Fort Lauderdale with Olympian and Florida Panthers alum Steven Kampfer at the Helm
16/02/2026
FORT LAUDERDALE, Fla., Feb. 16, 2026 (GLOBE NEWSWIRE) -- Matterhorn Fit, a cutting-edge fitness and rehabilitation facility, has officially opened its doors in Fort Lauderdale. Co-founded by Olympian and Florida [...]
Betterbrand Founder Turns Family Tragedy Into Clinically-Studied Lung Support
16/02/2026
Army medic–turned–PharmD launches BetterLungs™ after losing relatives to smoking-related respiratory illness SAN ANTONIO, Feb. 16, 2026 (GLOBE NEWSWIRE) -- Betterbrand, a PharmD-founded respiratory wellness company, [...]
IBA – ACQUISITION OF OWN SHARES
16/02/2026
Louvain-la-Neuve, Belgium, February 16 th , 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA [...]
EssilorLuxottica: Disclosure of transactions in own shares
16/02/2026
Disclosure of transactions in own shares Paris, France (February 16, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2025, EssilorLuxottica declares that [...]
Enlightened Recovery Opens New 22-Bed Residential Treatment Facility in Egg Harbor Township, NJ
16/02/2026
State-of-the-art residential rehab expands access to addiction treatment services in Southern New Jersey EGG HARBOR TOWNSHIP, N.J., Feb. 16, 2026 (GLOBE NEWSWIRE) -- Enlightened Recovery, a leading behavioral healthcare [...]
IBA – ACQUISITION D’ACTIONS PROPRES
16/02/2026
Louvain-la-Neuve, Belgique, 16 février 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
16/02/2026
Déclaration de transactions sur actions propres Paris, France (16 février 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2025, EssilorLuxottica déclare que le 13 février 2026 [...]
Juvenescence appoints Eileen Jennings-Brown as Chief Technology Officer and strengthens presence in UAE with new partnership and facilities with Masdar City
16/02/2026
Jennings-Brown will drive AI and technology strategy and lead the development of capabilities enabling discovery of therapeutics targeting fundamental aging mechanisms Offices in Abu Dhabi's premier biotechnology hub to [...]
Artios Strengthens Leadership Team to Accelerate Late-Stage Development of Potential First-in-Class Oncology Pipeline
16/02/2026
Roy W. Ware, PhD, MBA appointed as Chief Manufacturing and Technology Officer Caryn Barnett appointed as VP, Clinical Operations Pablo Lee, MD, MBA, appointed as VP, Medical Affairs CAMBRIDGE, United Kingdom and NEW [...]
Novo Nordisk A/S - share repurchase programme
16/02/2026
Bagsværd, Denmark, 16 February 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April [...]

Pages